| P2093 | author name string | K S Reynolds | |
| P2860 | cites work | Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling | Q33899320 |
| | Vaccine development in the twenty-first century: changing paradigms for elusive viruses | Q34099456 |
| | Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities. | Q36136786 |
| | Modeling within-host HIV-1 dynamics and the evolution of drug resistance: trade-offs between viral enzyme function and drug susceptibility | Q36492224 |
| | Model-based drug development | Q36830686 |
| | Quantitative disease, drug, and trial models | Q37292641 |
| | The animal rule and emerging infections: the role of clinical pharmacology in determining an effective dose | Q37538531 |
| | The forum for collaborative HIV research: a model for an integrated and inclusive approach to clinical research and drug development | Q37566190 |
| | Modeling long-term HIV dynamics and antiretroviral response: effects of drug potency, pharmacokinetics, adherence, and drug resistance. | Q51970556 |
| | Pharmacogenomic-guided drug development: regulatory perspective | Q78045528 |
| | Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice | Q81803899 |
| P433 | issue | 5 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 569-573 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Clinical pharmacology and viral infections | |
| P478 | volume | 88 | |